Company’s Copay ePA solution wins in Persistence/Adherence category
WHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today announced it was named Trailblazer 2020 Company of the Year in the supplier/vendor category by PM360, a leading trade magazine for the pharmaceutical, biotech, medical device and diagnostics industries. Nominated for a total of three awards, the company was also awarded top billing in the Persistence/Adherence category for its innovative Copay ePA solution.
For the last 12 years, the PM360 Trailblazer Awards have recognized outstanding companies, marketers, marketing teams, brand managers, and initiatives in healthcare marketing. To reach the finalist phase, companies must show achievement in innovation, talent development, and social responsibility.
“ConnectiveRx was founded with a mission to simplify how patients get on and stay on therapy. We work day in and day out to address the complexities facing patients, providers and pharmaceutical manufacturers through innovation and compassion,” said ConnectiveRx Chief Marketing Officer Danielle Daly. “Our nearly 1700 ConnectiveRx teammates all work with one purpose in mind — help patients connect to a healthier future. We are honored to be recognized by PM360 for delivering on that commitment.”
The PM360 Editorial Advisory Board, comprising forward-thinking leaders from their respective fields, judged nominations across nine overall categories. Winners were selected for their ability to stand out in the complex, ever-changing healthcare environment, and were judged on content, format, success in reaching targeted audience, and overall quality.
Winners were honored during a virtual celebration on October 1st and will be featured in the October issue of PM360.
ConnectiveRx is a leading technology-enabled biopharmaceutical services company that provides patient and provider support, access and adherence solutions for specialty and branded medications. The company’s services include the industry’s leading patient engagement and access platform (hub services), patient and provider adherence messaging, patient affordability programs, and the iconic Physicians’ Desk Reference, now known as the Prescribers’ Digital Reference. ConnectiveRx's wide array of services and innovative solutions accelerate speed-to-therapy and increase access and adherence resulting in improved outcomes for patients and healthcare overall.
ConnectiveRx has two main campus locations in Whippany, NJ and Pittsburgh, PA with additional locations in New Jersey, Pennsylvania, Missouri and California. To learn more, visit www.connectiverx.com or follow us on Twitter, LinkedIn and Facebook @ConnectiveRx.
Danielle Daly, ConnectiveRx